|
Post by fldave007 on Sept 2, 2015 13:52:50 GMT -5
Why can't someone in management contact Tom Hanks, Halle Berry or some other superstar actor/actress, athlete or celebrity and if appropriate have them use afrezza and prove to themselves its efficacy and convenience. Then explain how many people they could help by making a commercial extolling the virtues of Afrezza and pay them whatever they want. That would get the ball rolling and patients clamoring doctors offices and insurance companies. Who gives a damn if doctors are caught by surprise with patients asking for Afrezza if patients demand they will prescribe...Fldave
|
|
|
Post by mssciguy on Sept 2, 2015 14:01:35 GMT -5
Why can't someone in management contact Tom Hanks, Halle Berry or some other superstar actor/actress, athlete or celebrity and if appropriate have them use afrezza and prove to themselves its efficacy and convenience. Then explain how many people they could help by making a commercial extolling the virtues of Afrezza and pay them whatever they want. That would get the ball rolling and patients clamoring doctors offices and insurance companies. Who gives a damn if doctors are caught by surprise with patients asking for Afrezza if patients demand they will prescribe...Fldave Actually there was a review article from Nature Biotechnology circulated this morning on Stocktwits from years ago covering the Exubera failure.... on remark was "The TV commercials came too late...." That said, SNY is probably waiting until insurance coverage is available to give a really BIG push here, but.... why not let the tail wag the dog?
|
|
|
Post by nylefty on Sept 2, 2015 14:05:23 GMT -5
Why can't someone in management contact Tom Hanks, Halle Berry or some other superstar actor/actress, athlete or celebrity and if appropriate have them use afrezza and prove to themselves its efficacy and convenience. Then explain how many people they could help by making a commercial extolling the virtues of Afrezza and pay them whatever they want. That would get the ball rolling and patients clamoring doctors offices and insurance companies. Who gives a damn if doctors are caught by surprise with patients asking for Afrezza if patients demand they will prescribe...Fldave You make it sound so simple. Somehow I doubt that it's easy to just "contact" them and "have them use afrezza." These people are well protected from the hordes who would like to make money off them.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 2, 2015 15:18:41 GMT -5
Until insurance companies get on board, no point in spending loads of $ on advertising. Sanofi knows what it is doing, be patient.
|
|
|
Post by longstocking on Sept 2, 2015 15:52:06 GMT -5
Why can't someone in management contact Tom Hanks, Halle Berry or some other superstar actor/actress, athlete or celebrity and if appropriate have them use afrezza and prove to themselves its efficacy and convenience. Then explain how many people they could help by making a commercial extolling the virtues of Afrezza and pay them whatever they want. That would get the ball rolling and patients clamoring doctors offices and insurance companies. Who gives a damn if doctors are caught by surprise with patients asking for Afrezza if patients demand they will prescribe...Fldave It is truly amazing to me how many "investors" in this stock fail to complete their due diligence prior to investing in MNKD. If you would simply take the time to listen to the last two MNKD conference calls you would learn a ton of information, including the fact that AT THE EARLIEST, MNKD and SNY might have a TV commercial by year end. This is not difficult information to find. If you're not just a lazy day trader, then prove it by demonstrating that you have actually explored the MNKD website, found links to conference calls and other useful information and then considered it before investing. Combine the above with simple logic of economics, (i.e. if insurance doesn't cover it, people won't buy it), and the answer to why we don't see commercials yet, becomes obvious. My apologies if you find the above offensive. I'm just finding that in the last week the quality of the post has deteriorated from insightful opinions to jokes and lazy questions. Perhaps with just over 94K shares and close to $250K in this stock I am becoming irritated with seeing the same questions repeated over and over and over and over. Rant finished. Good luck all.
|
|
|
Post by mannmade on Sept 2, 2015 17:45:37 GMT -5
Until insurance companies get on board, no point in spending loads of $ on advertising. Sanofi knows what it is doing, be patient. Have to agree here and as I have posted several times before, it will likely cost Sanofi $500,000 or so just to produce a Network worthy commerical and if they use Tom Hanks or Halle Berry et al, it may cost another 1.5m or more. Then there is the media expense, and with any new product (and this is especially true with Afrezza,) you have a very low retention rate and you have to run an incredible amount of frequency and over several distribution channels including several broadcast networks (and primetime is not cheap even in today's world), cable and even Spanish Language and radio to get a sufficient amount of audience coverage. This could easily add up to 10's of millions of dollars just for the first run/cycle of commercials, which would have to be repeated throughout the year. So as has been said it would, at this point, pretty much be a complete waste of money. And with January soon upon us I again expect to start hearing cries for a SB commercial which would be an even bigger proportionite waste of money. Aside form the production costs which because of the way viewers and advertisers now look at Super Bowl commercials it could cost twice that of a non SB commercial for production. And the media costs for one :30 spot is likely to be between 4 to $5 million for the next SB. Just for info these are my personal opinions but based on the following experience; I was a SVP in Integrated Sales and Marketing for 5 years at NBC and we sold and produced many campaigns. Also I started and ran (w a partner) my own Advertising and Marketing Company for 17 years and separately a promotions agency. Our clients included Pepsi, GM, Sony, Jet Blue, etc..
|
|
|
Post by cjc04 on Sept 2, 2015 18:18:39 GMT -5
Until insurance companies get on board, no point in spending loads of $ on advertising. Sanofi knows what it is doing, be patient. Have to agree here and as I have posted several times before, it will likely cost Sanofi $500,000 or so just to produce a Network worthy commerical and if they use Tom Hanks or Halle Berry et al, it may cost another 1.5m or more. Then there is the media expense, and with any new product (and this is especially true with Afrezza,) you have a very low retention rate and you have to run an incredible amount of frequency and over several distribution channels including several broadcast networks (and primetime is not cheap even in today's world), cable and even Spanish Language and radio to get a sufficient amount of audience coverage. This could easily add up to 10's of millions of dollars just for the first run/cycle of commercials, which would have to be repeated throughout the year. So as has been said it would, at this point, pretty much be a complete waste of money. And with January soon upon us I again expect to start hearing cries for a SB commercial which would be an even bigger proportionite waste of money. Aside form the production costs which because of the way viewers and advertisers now look at Super Bowl commercials it could cost twice that of a non SB commercial for production. And the media costs for one :30 spot is likely to be between 4 to $5 million for the next SB. Just for info these are my personal opinions but based on the following experience; I was a SVP in Integrated Sales and Marketing for 5 years at NBC and we sold and produced many campaigns. Also I started and ran (w a partner) my own Advertising and Marketing Company for 17 years and separately a promotions agency. Our clients included Pepsi, GM, Sony, Jet Blue, etc.. Mannmade, your patience with that answer is impressive. There are 100 reasons we do not need a commercial right now,,,,, the 1 I can't get past is production. Everyone wants a path to blockbuster status, pronto! But as far as I'm aware, MNKD, with 3 production lines, is only capable of producing enough product for around 450k patients annually, and requires 6 months to build out more lines. MNKD wouldn't be able to handle the result of a successful TV commercial campaign and the projected growth rate we all hope would come with it. So my question is, what is SNY really doing about production plans? Unanswerable question, I know... The secrets and silence is what is pissing me off..., we're either patient investors who "believe in the science" or fools who are being dragged along. It is painfully obvious that MNKD mgmt is waiting for something, their handling of this debt is the most recent example of that. I really hope it's something substantial and not just fingers crossed hoping for better script #'s like we do every Friday....
|
|
|
Post by brentie on Sept 2, 2015 18:27:03 GMT -5
|
|
|
Post by bradleysbest on Sept 2, 2015 18:30:34 GMT -5
When the next phase of DTC begins it will include radio, billboards etc.... it won't just be TV commercials. Havas will hit them ( the public) with a full court press. Can't wait for insurance companies to get with the program. Then it's game on!
|
|
|
Post by dreamboatcruise on Sept 3, 2015 14:49:10 GMT -5
Why can't someone in management contact Tom Hanks, Halle Berry or some other superstar actor/actress, athlete or celebrity and if appropriate have them use afrezza and prove to themselves its efficacy and convenience. Then explain how many people they could help by making a commercial extolling the virtues of Afrezza and pay them whatever they want. That would get the ball rolling and patients clamoring doctors offices and insurance companies. Who gives a damn if doctors are caught by surprise with patients asking for Afrezza if patients demand they will prescribe...Fldave A) Until formulary placement improves, the expense of TV ads at all is likely questionable, much less "whatever it costs, megastar" ads. B) The FDA constraints on what can be said in ads probably diminishes the usefulness of celebs. The FDA does not allow ads that talk about one person's own experiences with regard to anything that comes even close to a clinical issue... i.e. Tom Hanks might be able to say "This is great because it's so small", but he undoubtedly could not say "my A1c dropped by 2 points" or "I had no hypos". Paying a megastar to smile while all of the fine print of the label and complications are read off is likely not a great use of money. My $0.01 worth (I no longer have $0.02 to expend on my opinions with recent portfolio performance)
|
|
|
Post by yossarian on Sept 3, 2015 14:53:44 GMT -5
TIME Magazine - another AFREZZA ad
|
|
|
Post by mssciguy on Sept 3, 2015 15:09:41 GMT -5
Ah yep, you know Al can pull the strings if he wants to en.wikipedia.org/wiki/Alfred_E._MannHe just doesn't want to, apparently. But, Hakan seems like an honest guy. He said September.....
|
|
|
Post by newmnkdinvestor on Sept 3, 2015 16:43:24 GMT -5
I need some green my life.
|
|
|
Post by mannmade on Sept 3, 2015 17:13:56 GMT -5
I need some green my life. If you need Green in your life right now I suggest wheat grass. At least it's healthy for you...
|
|
|
Post by pktrump on Sept 3, 2015 17:52:02 GMT -5
Love the idea of Tom Hanks, but step one is for Endos to accept and visibly endorse via articles. Would think an article from Mayo or Hopkins for example describing the experience and results of a 100+ patients would do more for AFZ acceptance than anything at this stage. I think it will happen at some point given what we have witnessed on social media and on what Al Mann has said all along. WE need another vector of legitimacy (Al Mann and 2 billion in development cost are good enough for me) from a major Endo society and/or major academic center: the study does not need necessarily to be a comparitive analysis vs placebo or insulin pins, just a Specialist's "perspective" and experience with AFZ and what their thoughts are on how AFZ disrupts the current status quo. The status quo being injections of relatively long acting insulins into the subQ fat with unreliable and mentally taxing pharmokinetics and carb counting; the status quo having decades of proof of doing nothing but maybe prolonging life but not slowing the progression of dz with daily out of control post prandial glucose excursions.
Dialysis centers, opthalmalogy clinincs, wound care clinics, ERs, etc.. are filled with patients these days, the vast majority of patients having Diabetes related complications. When something can't last, it will end; thats how I look at the current status quo Tx. One recent positive for AFZ is people are awakening to the complications and inherent problems of Oral Hypoglycemics, which IMO increase stress on Beta cells. AFZ should be first line of defense.
|
|